Endoscopic therapeutic options for type 2 diabetes

Nenhuma Miniatura disponível
Citações na Scopus
0
Tipo de produção
bookPart
Data de publicação
2015
DOI
Scopus
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER INTERNATIONAL PUBLISHING
Autores
ORSO, I. R. B.
Citação
De Moura, E. G. H.; Orso, I. R. B.; Martins, B. C.; Lopes, G. S.. Endoscopic therapeutic options for type 2 diabetes. In: . OBESITY AND DIABETES: SPRINGER INTERNATIONAL PUBLISHING, 2015. p.131-142.
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The global obesity epidemic is expected to worsen with a concomitant increase in the comorbid conditions. Obesity is a major risk factor for type 2 diabetes, and it is not surprising that the global prevalence of this disease continues to increase. Given the emerging role of endoscopic procedures in the treatment of obesity and rapid changes in endoscopic technologies and techniques, this review considers the current state of endoscopic management of obesity and type 2 diabetes. Endoluminal interventions performed entirely through the gastrointestinal tract by using endoscopic devices offer the potential for an outpatient weight loss procedure that may be safer, less invasive, and more cost-effective, compared to current surgical approaches. Endoscopic techniques attempt to mimic some of the anatomic features of bariatric surgery and rely on gastric restriction and/or duodenal exclusion. In this chapter we will describe the two endoscopic methods that have much endorsement of the literature in relation to type 2 diabetes and are in current clinical use-the intragastric balloon and the duodenojejunal bypass liner. © Springer International Publishing Switzerland 2015.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/51222
Referências
  1. Blackburn, G., Effect of degree of weight loss on health benefits (1995) Obes Res, 3, pp. 211S-216S
  2. Bogers, R.P., Bemelmans, W.J., Hoogenveen, R.T., Boshuizen, H.C., Woodward, M., Knekt, P., van Dam, R.M., Shipley, M.J., Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: A meta-analysis of 21 cohort studies including more than 300,000 persons (2007) Arch Intern Med, 167 (16), pp. 1720-1728
  3. Buchwald, H., Avidor, Y., Braunwald, E., Jensen, M.D., Pories, W., Fahrbach, K., Schoelles, K., Bariatric surgery: A systematic review and meta-analysis (2004) JAMA, 292 (14), pp. 1724-1737
  4. Buzga, M., Evzen, M., Pavel, K., Tomas, K., Vladislava, Z., Pavel, Z., Svagera, Z., Effects of the intragastric balloon MEDSIL® on weight loss, fat tissue, lipid metabolism, and hormones involved in energy balance (2014) Obes Surg, 24, pp. 909-915. , http://dx.doi.org/10.1007/s11695-014-1191-4:10.1007/s11695-014-1191-4
  5. Cerezo, C., Segura, J., Praga, M., Ruilope, L.M., Guidelines updates in the treatment of obesity or metabolic syndrome and hypertension (2013) Curr Hypertens Rep, 15, pp. 196-203. , http://dx.doi.org/10.1007/s11906-013-0337-4:10.1007/s11906-013-0337-4, Epub March 2013
  6. Cohen, R.V., Galvao Neto, M., Correa, J.L., Sakai, P., Martins, B.C., Schiavon, C.A., Petry, T., Sorli, C., A pilot study of the duodenal-jejunal bypass liner in low body mass index type 2 diabetes (2013) J Clin Endocrinol Metab, 98 (2), pp. E279-E282
  7. Dumonceau, J.M., Evidence-based review of the bioenterics intragastric balloon for weight loss (2008) Obes Surg, 18, pp. 1611-1617
  8. Flum, D.R., Dellinger, E.P., Impact of gastric bypass operation on survival: A population-based analysis (2004) J Am Coll Surg, 199, pp. 543-551
  9. Forlano, R., Ippolito, A.M., Iacobellis, A., Effect of the bioenterics intragastric balloon on weight, insulin resistance, and liver steatosis in obese patients (2010) Gastrointest Endosc, 71, pp. 927-933
  10. Genco, A., López-Nava, C., Wahlen, C., Maselli, R., Cipriano, M., Sanches, M.M.A., Jacobs, C., Lorenzo, M., Multi-centre European experience with intragastric balloon in overweight populations: 13 years of experience (2013) Obes Surg, 23, pp. 515-521
  11. Gersin, K.S., Keller, J.E., Stefanidis, D., Duodenal-jejunal bypass sleeve: A totally endoscopic device for the treatment of morbid obesity (2007) Surg Innov, 14 (4), pp. 275-278
  12. Herve, J., Wahlen, C.H., Schaeken, A., What becomes of patients one year after the intragastric balloon has been removed? (2005) Obes Surg, 15, pp. 864-870
  13. Imaz, I., Martínez-Cervell, C., García-Alvarez, E.E., Safety and effectiveness of the intragastric balloon for obesity (2008) A meta-analysis. Obes Surg, 7, pp. 841-846
  14. Jonge, C., Rensen, S.S., Verdam, F., Vincent, J.R.P., Bloom, S.R., Buurman, W.A., Roux, C.W., Greve, D.J.W., Endoscopic duodenal-jejunal bypass liner rapidly improves type 2 diabetes (2013) Obes Surg, 23, pp. 1354-1360. , http://dx.doi.org/10.1007/s11695-013-0921-3:10.1007/s11695-013-0921-3
  15. Kumar, N., Thompson, C.C., Endoscopic solutions for weight loss (2011) Curr Opin Gastroenterol, 27, pp. 407-411
  16. Lee, W.J., Lee, Y.C., Ser, K.H., Chen, J.C., Chen, S.C., Improvement of insulin resistance after obesity surgery: A comparison of gastric banding and bypass procedures (2008) Obes Surg, 18, pp. 1119-1125
  17. Levine, A., Ramos, A.C., Escalona, A., Rodriguez-Grunet, L., Greve, J.W., Janssen, I., Rothstein, R., Neto, M.G., Radiographic appearance of endoscopic duodenal-jejunal bypass liner for treatment of obesity and type 2 diabetes (2009) Surg Obes Relat Dis, 5 (3), pp. 371-374
  18. Mathus-Vliegen, E.M., Tytgat, G.N., Intragastric balloon for treatment-resistant obesity: Safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon-free follow-up (2005) Gastrointest Endosc, 61, pp. 19-27
  19. McLaughlin, T., Abbasi, F., Cheal, K., Chu, J., Lamendola, C., Reaven, G., Use of metabolic markers to identify overweight individuals who are insulin resistant (2003) Ann Intern Med, 139, pp. 802-809
  20. McLaughlin, T., Reaven, G., Abbasi, F., Lamendola, C., Saad, M., Waters, D., Simon, J., Krauss, R.M., Is there a simple way to identify insulin resistant individuals at increased risk of cardiovascular disease? (2005) Am J Cardiol, 96 (3), pp. 399-404
  21. Moura, E.G.H., Orso, I.R.B., Martins, B.C., Lopes, G.S., Oliveira, S.L., Galvão-Neto, M.P., Mancini, M.C., Cecconello, I., Improvement of insulin resistance and reduction of cardiovascular risk among obese patients with type 2 diabetes with the duodenojejunal bypass liner (2011) Obes Surg, 21, pp. 941-947
  22. Moura, E.G.H., Martins, B.C., Lopes, G.S., Orso, I.R.B., Oliveira, S.L., Mancini, M.C., Galvão Neto, M.P., Cecconello, I., Six months results of the duodenal-jejunal bypass liner for the treatment of obesity and type 2 diabetes (2011) J Gastroint Dig Syst, 2 (5)
  23. Moura, E.G.H., Martins, B.C., Lopes, G.S., Orso, I.R., Oliveira, S.L., Galvão, M.P., Metabolic improvements in obese type 2 diabetes subjects implanted for 1 year with an endoscopically deployed duodenal-jejunal bypass liner (2012) Diabetes Technol Ther, 14 (2), pp. 183-189. , http://dx.doi.org/10.1089/dia.2011.0152:10.1089/dia.2011.0152
  24. Rubino, F., Forgione, A., Cummings, D.E., Vix, M., Gnulli, D., Mingnone, G., The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes (2006) Ann Surg, 244 (5), pp. 741-749
  25. Rodriguez-Grunert, L., Neto, M.P.G., Alamo, M., Ramos, A.C., Baez, P.B., Tarnoff, M., First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve (2008) Surg Obes Relat Dis, 4 (1), pp. 55-59
  26. Schauer, P., Chand, B., Brethauer, S., New applications for endoscopy: The emerging field of endoluminal and transgastric bariatric surgery (2007) Surg Endosc, 21, pp. 347-356
  27. Schouten, R., Rijs, C.S., Bouvy, N.D., Hameeteman, W., Koek, G.H., Janssen, I.M., Greve, J.W., A multicenter, randomized efficacy study of the EndoBarrier™ gastrointestinal liner for presurgical weight loss prior to bariatric surgery (2010) Ann Surg, 251 (2), pp. 236-243
  28. Shishehbor, M.H., Hoogwef, B.J., Lauer, M.S., Association of triglyceride to HDL cholesterol ratio with heart rate recovery (2004) Diabetes Care, 27 (4), pp. 936-941
  29. Tarnoff, M., Rodriguez-Grunet, L., Escalona, A., Ramos, A.C., Galvão-Neto, M.P., Alamo, M., Reyes, E., Ibanez, L., Open label, prospective, randomized controlled trial of an endoscopic duodenal-jejunal bypass sleeve versus low calorie diet for pre-operative weight loss in bariatric surgery (2009) Surg Endosc, 23 (3), pp. 650-656
  30. Tarnoff, M., Shikora, S., Lembo, A., Gersin, K., Chronic in vivo experience with an endoscopically delivered and retrieved duodenal-jejunal bypass sleeve in a porcine model (2008) Surg Endosc, 22 (4), pp. 1023-1028
  31. Zechmeister-Koss, I., Huić, M., Fischer, S., The duodenal-jejunal bypass liner for the treatment of type 2 diabetes mellitus and/or obesity: A systematic review (2014) Obes Surg, 24, pp. 310-323. , http://dx.doi.org/10.1007/s11695-013-1137-2:10.1007/s11695-013-1137-2

Coleções
Livros e Capítulos de Livros - HC/ICESP
Livros e Capítulos de Livros - HC/ICHC
Livros e Capítulos de Livros - LIM/35
Livros e Capítulos de Livros - ODS/03